About 2.01 million shares traded. AbbVie Inc. (NYSE:ABBV) has risen 10.63% since December 4, 2016 and is uptrending.
Patriot Financial Partners Gp Lp decreased its stake in Sterling Bancorp (STL) by 16.01% based on its latest 2017Q2 regulatory filing with the SEC. The company has market cap of $555.50 million. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 0.95% with $1.59 Billion sitting short, betting on future declines. The shares were sold at an average price of $85.02, for a total value of $705,666.00. The Blackstone Group L.P. (NYSE:BX) has risen 20.49% since December 5, 2016 and is uptrending. It has outperformed by 10.26% the S&P500.
The stock increased 1.14% or $1.09 during the last trading session, reaching $96.31. Its up 0.01, from 0.99 in 2017Q1. It is positive, as 55 investors sold ABBV shares while 581 reduced holdings.
Other hedge funds also recently added to or reduced their stakes in the company.
AbbVie Inc.'s insider ownership stands at 0.1 percent, while its insider transaction is -30.42 percent. Vigilant Capital Management Llc acquired 5,980 shares as Abbvie Inc (ABBV)'s stock rose 6.17%. (NYSE:ABBV) for 127,656 shares. Foyston Gordon And Payne has 12,275 shares for 0.19% of their portfolio. Analysts reported that the Price Target for AbbVie Inc. might touch $135 high while the Average Price Target and Low price Target is $99.14 and $60 respectively. Ironwood Fin Ltd Company has 0.01% invested in AbbVie Inc. Hence the difference between Predicted EPS and Actual EPS reported is $0.02/share which shows an Earnings Surprise of 1.4 Percent. It also upped Kla (NASDAQ:KLAC) stake by 9,551 shares and now owns 34,005 shares. Tiedemann Wealth Management Lc has 21,881 shares. 14,201 are held by Security Bank & Trust Of So Dak. Condor Management holds 1.14% or 74,457 shares in its portfolio. Schmidt P J Mngmt Inc accumulated 1.96% or 88,981 shares. (NYSE:ABBV). Acadian Asset Mgmt Limited Co reported 0% in AbbVie Inc. WealthTrust Axiom LLC grew its position in shares of AbbVie by 0.3% during the second quarter.
Since June 14, 2017, it had 0 buys, and 2 insider sales for $8.79 million activity.
Among 21 analysts covering Abbvie Inc (NYSE:ABBV), 11 have Buy rating, 1 Sell and 9 Hold.
AbbVie Inc. (ABBV)'s RSI (Relative strength index) is at 62.04, its ATR (Average True Range) value is 2.19, while its Beta factor was calculated at 1.52. Therefore 52% are positive.
In other AbbVie news, EVP Michael Severino sold 25,633 shares of the business's stock in a transaction dated Friday, November 10th. (NYSE:ABBV) has "Hold" rating given on Friday, July 28 by Cowen & Co. As per Friday, October 13, the company rating was maintained by Barclays Capital. Jefferies Group reissued a "buy" rating and set a $107.00 price objective (up from $94.00) on shares of AbbVie in a research report on Friday, September 15th. The firm has "Mkt Perform" rating given on Tuesday, October 18 by Leerink Swann. BMO Capital Markets maintained AbbVie Inc. The rating was maintained by Credit Suisse on Thursday, July 20 with "Hold". AbbVie has an average rating of Buy and a consensus target price of $96.72. Finally, Piper Jaffray Companies lifted their price objective on shares of AbbVie to $115.00 and gave the company an overweight rating in a research note on Friday, October 27th. Abbvie Inc now has $152.01 billion valuation. Analysts on average have given a price target of $99.85 to AbbVie Inc. stock. (NYSE:ABBV) were released by: Seekingalpha.com and their article: "AbbVie's risankizumab successful in fourth late-stage psoriasis study" published on December 04, 2017 as well as Nasdaq.com's news article titled: "AbbVie Psoriasis Candidate Succeeds in 4th Phase III Study" with publication date: December 05, 2017. Maryland Mgmt reported 0.61% in AbbVie Inc. (NYSE:ABBV) or 14,182 shares. During the same quarter previous year, the business posted $1.15 EPS. ABBV's profit will be $2.28B for 16.84 P/E if the $1.43 EPS becomes a reality. Glenview Natl Bank Trust Dept stated it has 1.24% in AbbVie Inc. The company had revenue of $7 billion for the quarter, compared to analyst estimates of $7 billion. Verizon Communications Inc. (NYSE:VZ) was raised too. The company reported $1.28 earnings per share for the quarter, topping the Zacks' consensus estimate of $1.26 by $0.02. 43 funds opened positions while 80 raised stakes. 10,057 are owned by Needelman Asset Mgmt. Montecito Financial Bank Tru holds 0.37% in AbbVie Inc. Focused Wealth Management has 1,402 shares. A D Beadell Counsel reported 2.14% stake. First Manhattan accumulated 50,836 shares. Kayne Anderson Rudnick Inv Limited Liability Corp accumulated 3,300 shares or 0% of the stock. Barton stated it has 8,994 shares or 0.17% of all its holdings. Opus Cap Group Incorporated Ltd Com invested in 0.12% or 8,338 shares. Capstone Asset has 23,799 shares. (NYSE:ABBV). Tortoise Inv Mngmt Ltd Liability Corp owns 323 shares or 0.01% of their United States portfolio. United Bancorporation Va owns 4,958 shares or 0.35% of their U.S. portfolio.
Wynnefield Capital Inc holds 3.78% of its portfolio in Summer Infant, Inc. for 6.40 million shares.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.